Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 770 clinical trials
  • None views
  • None views
  • None views
  • None views
  • None views
Diagnostic Criteria of ARDS at High Altitudes in Western China

The severity of ARDS in high altitude areas was classified according to the Berlin standard high altitude area Oxygenation.

pneumonia
aspiration pneumonitis
shock
systemic infection
positive end expiratory pressure
  • 0 views
  • 19 Feb, 2024
Lyon Granulomatous Hepatitis Study

Five percent of patients die of their disease, mainly because of respiratory distress. Hepatic involvement is most often asymptomatic or pauci-symptomatic (moderate cholestasis and conglomerates of granulomas visible on imaging).

  • 0 views
  • 19 Feb, 2024
A Longitudinal Study of COVID-19 Sequelae and Immunity

Background COVID-19 is a disease caused by the SARS-CoV-2 virus. It infects the respiratory tract. Some people who get COVID-19 have only mild symptoms. But for others, infection leads to pneumonia, respiratory failure, and, in some cases, death. Researchers want to learn more about any effects that may persist after …

pneumonia
SARS
acute respiratory syndrome (sars)
antigen test
leukapheresis
  • 0 views
  • 19 Feb, 2024
Surfactant Administration Via Thin Catheter Using a Specially Adapted Video Laryngoscope - the VISUAL Method

Surfactant administration via thin catheter using a specially adapted video laryngoscope - a prospective, multicenter trial, assessing the feasibility of the VISUAL method (Video Surfactant Administration Laryngoscopy). The study will search for the number of attempts until surfactant is administrated, assessment of the infants' stability during the procedure, duration of …

pulmonary surfactant
premature birth
respiratory distress
prematurity
intermittent positive pressure ventilation
  • 0 views
  • 19 Feb, 2024
Hemostasis in COVID-19: an Adaptive Clinical Trial

Hypercoagulability has been demonstrated in COVID-19, leading to respiratory distress and increased mortality. This is adaptive clinical trial to compare effectiveness and safety of four therapeutic strategies in hospital mortality in patients with COVID-19: standard prophylaxis, therapeutic dose anticoagulation, inhaled UFH associated with standard prophylaxis and ASA associated with standard …

hemostasis
enoxaparin
respiratory distress
covid-19
hypercoagulability
  • 0 views
  • 19 Feb, 2024